Does EVOLOCUMAB Cause Myalgia? 5,061 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5,061 reports of Myalgia have been filed in association with EVOLOCUMAB (REPATHA). This represents 3.4% of all adverse event reports for EVOLOCUMAB.
5,061
Reports of Myalgia with EVOLOCUMAB
3.4%
of all EVOLOCUMAB reports
15
Deaths
177
Hospitalizations
How Dangerous Is Myalgia From EVOLOCUMAB?
Of the 5,061 reports, 15 (0.3%) resulted in death, 177 (3.5%) required hospitalization, and 9 (0.2%) were considered life-threatening.
Is Myalgia Listed in the Official Label?
Yes, Myalgia is listed as a known adverse reaction in the official FDA drug label for EVOLOCUMAB.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Drug dose omission (4,914)
Injection site bruising (4,409)
Device use error (4,002)
What Other Drugs Cause Myalgia?
ATORVASTATIN (7,155)
ROSUVASTATIN (3,958)
SIMVASTATIN (3,919)
ADALIMUMAB (3,134)
DUPILUMAB (3,064)
DENOSUMAB (2,965)
LEVOTHYROXINE (2,467)
CIPROFLOXACIN (2,291)
EZETIMIBE (2,066)
TERIPARATIDE (1,904)
Which EVOLOCUMAB Alternatives Have Lower Myalgia Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE